Serum IL27 in Relation to Risk of Hepatocellular Carcinoma in Two Nested Case-Control Studies.
Woon-Puay KohYue WangRenwei WangHung Nguyen LuuJennifer Adams-HaduchWoon Puay KohYu-Tang GaoJaideep BehariMichael T LotzePublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2020)
IL27, through its immunosuppressive property, may play a significant role in the development of hepatocellular carcinoma. Serum levels of IL27 may be used as a biomarker for prediction of hepatocellular carcinoma development.
Keyphrases